For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in estimated glomerular filtration rate (eGFR) than placebo, ...
Aug 22, 2023
0
1
For high-risk outpatients with COVID-19, treatment with oral fluvoxamine plus budesonide reduces the incidence of severe disease needing advanced care, according to a study published online April 18 in the Annals of Internal ...
Apr 18, 2023
0
2
The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in ...
Apr 13, 2022
0
3
Early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home or in other community settings.
Apr 13, 2021
0
17
Early treatment with a medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalization in people with COVID-19, researchers at the University of Oxford have found.
Feb 10, 2021
0
8
(HealthDay)—The addition of budesonide to a saline nasal lavage for the treatment of chronic rhinosinusitis provides clinically meaningful benefits, according to a study published online June 7 in JAMA Otolaryngology-Head ...
Jul 9, 2018
0
1
Use of inhaled corticosteroids was linked with an increased risk of pneumonia in a study of individuals with asthma.
Apr 20, 2017
0
1
